Zynerba Pharmaceuticals Inc 's

• ZYNE's Stock Performance relative to its Competitors

Verrica Pharmaceuticals Inc Share Performance -19.28% This Quarter

Verrica Pharmaceuticals Inc Profile Verrica Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing medical solutions for dermatological conditions. Their business model revolves around identifying unmet needs in the dermatology market, conducting rigorous clinical research to develop novel therapies, and efficiently bringing these treatments to market through strategic partnerships and collaborations. Verrica Pharmaceuticals aims to enhance patient outcomes by addressing specific dermatological conditions with innovative solutions. More about Verrica Pharmaceuticals Inc 's Market Share

Gt Biopharma Inc Share Performance +1,509.81% This Quarter

Gt Biopharma Inc Profile Gt Biopharma Inc's business model revolves around developing innovative immunotherapies for the treatment of various cancers. The company focuses on harnessing the power of the immune system to target and eliminate cancer cells through its proprietary technology platform. Gt Biopharma Inc aims to advance its therapies through clinical trials and ultimately commercialize them for the benefit of patients worldwide. More about Gt Biopharma Inc 's Market Share

Grace Therapeutics Inc Share Performance -31.41% One Year

Grace Therapeutics Inc Profile The company develops drug delivery formulations for rare and orphan diseases. More about Grace Therapeutics Inc's Market Share

Gelesis Holdings Inc Share Performance -69.50% This Quarter

Gelesis Holdings Inc Profile Gelesis Holdings Inc's business model involves developing and commercializing medical devices and therapies to provide non-invasive treatments for obesity and other related conditions. More about Gelesis Holdings Inc 's Market Share

Galmed Pharmaceuticals Ltd Share Performance +680.78% 30 Days

Galmed Pharmaceuticals Ltd Profile Galmed Pharmaceuticals Ltd's business model focuses on the development and commercialization of innovative therapeutic solutions, particularly in the field of liver and metabolic diseases. More about Galmed Pharmaceuticals Ltd 's Market Share

Sources: Zynerba Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 6:37 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Zynerba Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.